James Hardie shorts explode — and uranium’s still the main game

This Week's Analysis

JHX went from a rounding error to a target. In a single week, shorts jumped 0.78% → 3.25% (+2.47%). That’s not a drift higher — that’s a desk deciding the housing-linked global cyclicals are where you swing, especially when rates won’t behave.

BOE (23.68%, -0.74%) stays welded to the top of the table, but the small unwind matters: some shorts are banking profit rather than pressing. The bet hasn’t changed — execution. BOE is ramping Honeymoon and pushing Alta Mesa, and the market’s happy to fade any restart story where timelines and costs can slip (see BOE’s Dec-24 quarterly results presentation: http://www.bossenergy.com/images/documents/Dec24-Quarterly-Results-Presentation.pdf). PDN (16.26%, +1.74%) is the opposite flow: shorts piled in. For a large-cap uranium name, +1.74% in a week is a statement. The simplest read is the sector trade getting more stock-specific — PDN now wears both uranium price sensitivity and post-deal integration risk after the Fission acquisition (PDN annual report: https://www.paladinenergy.com.au/wp-content/uploads/2025/10/Paladin-2025AnnualReport-Full-Web.pdf). The lithium complex remains a grind. PLS (12.57%, +0.07%) barely moved, but MIN (12.05%, +0.43%) and LTR (10.34%, +0.32%) ticked higher — the kind of steady accumulation that tells you the market still doesn’t trust the earnings floor. MIN’s short build is the more revealing one because it’s not a pure-play punt; it’s a bigger, diversified operator being treated like a macro commodity expression (MIN FY results: https://cdn.sanity.io/files/o6ep64o3/production/b23c9b1f93dbe5cc41520061cafecf0c1d214c77.pdf). Outside resources, the consumer names stay on the grill: DMP at 11.69% (+0.15%) and CTT at 9.93% (+0.49%). No drama in the weekly change — just persistent disbelief that margins and demand will both cooperate at the same time. IEL (12.08%, -1.07%) was the cleanest unwind in the top 10. It’s still heavily shorted, but direction matters: shorts reduced risk here while adding elsewhere.

Movers Analysis

JHX (+2.47% to 3.25%) was the week’s loudest repositioning. A move from sub-1% to above 3% in one week is rare for a $19.6B name. This reads like a rates-and-cycle trade: building products are leveraged to construction activity, and when yields stay higher, the market starts leaning against anything tied to housing volumes and renovation spend. PDN (+1.74% to 16.26%) was the other big swing. When shorts add that quickly in a crowded sector, it’s usually positioning into a catalyst — or a view that the long side has become complacent. ZIP (+1.52% to 4.59%) is classic consumer-credit caution. The recent capital structure admin (cessation/unquoted securities notices) keeps the share count and dilution maths front-of-mind — exactly the kind of detail shorts like to weaponise (ZIP cessation notice: https://yourir.info/ezapi/announcements/dbc6d3e76afbc820/2A1648337/ZIP_Notification_of_cessation_of_securities_ZIP.pdf). HLI (+1.39% to 2.07%) and CTD (+1.03% to 7.29%) also saw meaningful adds. CTD’s move lands in a market already focused on balance sheet settings (CTD debt facilities amendment: https://investor.travelctm.com.au/wp-content/uploads/2025/12/Agreement-to-Amend-Debt-Facilities.pdf). On the cover side, ADT (7.46% → 5.94%, -1.52%) and OPT (4.46% → 3.38%, -1.08%) saw real short covering. ADT’s drop is consistent with traders taking money off the table as the Vares project edges closer to delivery; OPT’s cover fits biotech reality — timing binary outcomes is a good way to get carried out.